AC-5216
AC-5216 性质
| 储存条件 | 2-8°C |
|---|---|
| 溶解度 | DMF:30mg/mL; DMF:PBS (pH 7.2) (1:20):0.05 mg/mL;二甲基亚砜:5mg/mL |
| 形态 | 粉末 |
| 颜色 | 白色至米色 |
| InChI | 1S/C23H23N5O2/c1-3-27(15-17-10-6-4-7-11-17)20(29)16-28-22-19(26(2)23(28)30)14-24-21(25-22)18-12-8-5-9-13-18/h4-14H,3,15-16H2,1-2H3 |
| InChIKey | NBMBIEOUVBHEBM-UHFFFAOYSA-N |
| SMILES | CN(C1=CN=C(C2=CC=CC=C2)N=C1N3CC(N(CC)CC4=CC=CC=C4)=O)C3=O |
AC-5216 用途与合成方法
| Target | Value |
|
mMBR(Brain)
(Cell-free assay) | 0.297 nM(Ki) |
|
MBR
(human glioma cells-based assay) | 2.73 nM |
|
MBR
(rat glioma cells-based assay) | 3.04 nM |
Emapunil (AC-5216, 0.1-3, 0.003-0.01 and 0.01-0.3 mg/kg, p.o.) produces anti-anxiety effects in the Vogel-type conflict test in rats, and in the light/dark box and social interaction tests in mice.
Emapunil (AC-5216, 3-30 mg/kg, p.o.) reduces the immobility time, and this effect was blocked by PK11195.
Emapunil (AC-5216, 1-100 mg/kg, p.o.) produces no distinct change in the rat electroencephalogram.
Emapunil (AC-5216, 0.3 and 1 mg/kg, i.g.) causes significant suppression of the enhanced anxiety and contextual fear induced in post-TDS rats.
Emapunil (AC-5216, 0.3 and 1 mg/kg, i.g.) alleviates the enhanced anxiety and fear response in a time-dependent sensitization (TDS) procedure, a rat PTSD animal model.
Emapunil (AC-5216, 0.3 and 1 mg/kg, i.g.) reverses the increased plasma glucose (PG) and decreased insulin (INS) in HFD-STZ rats.
| Animal Model: | Rats. |
| Dosage: | 0.1-3 mg/kg. |
| Administration: | P.O.. |
| Result: |
Significantly increased the number of shocks that rats received.
Significantly increased the time spent in the light compartment but only slightly increased that time at 0.03 mg/kg, p.o. (P<0.1). |
AC-5216 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026-09-15 | HY-15527R | AC-5216 | 226954-04-7 | 5 mg | 1900 |
| 2026-09-15 | HY-15527 | 226954-04-7 | 1 mg | 400 |